Carpal Tunnel Syndrome Drug Market - Industryt
Carpal Tunnel Syndrome Drug Market - Industry Trends and Forecast to
2027 with key market like ALLERGAN, Pfizer Inc, Johnson & Johnson Services,
Inc, Novartis AG, Teva Pharmaceutical Industries Ltd, Bristol-Myers Squibb
Company, WOCKHARDT
Carpal
Tunnel Syndrome Drug Market By Mechanism of Action (Analgesics, NSAIDs,
Corticosteroids and Others), Drugs (Ibuprofen, Prednisone, Triamcinolone and
Others), Treatment (Medication, Integrative Therapy, and Surgery), Route of
Administration (Oral and Parenteral), Distribution Channel (Hospital Pharmacy,
Retail Pharmacy, Online Pharmacy), End-Users (Hospitals, Homecare, Specialty
Clinics and Others), Geography (North America, Europe, Asia-Pacific, South
America, Middle East and Africa) - Industry Trends and Forecast to 2027
Market Analysis: Global
Carpal Tunnel Syndrome Drug Market
Carpal tunnel syndrome
drug market is growing at a steady CAGR in the forecast period of 2021-2027.
The report contains data of the base year 2019 and historic year 2018. This
rise in market value can be attributed to the growing prevalence of carpal
tunnel syndrome.
Market Outlook:: Global
Carpal Tunnel Syndrome Drug Market
Carpal tunnel syndrome
is also known as median nerve compression neuropathy which is characterized by
moderate to severe pain, numbness, tingling or weakness in the upper extremity
of the body hand and arm. This condition results when one of the major nerves,
the median nerve which passes through the hand gets squeezed or
compressed. The median nerve provides sensation to the thumb and fingers.
Carpal tunnel syndrome can occur in one or both hands.
Download full
sample report of Carpal Tunnel Syndrome Drug Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-carpal-tunnel-syndrome-drug-market
According to the Bureau of Labor and Statistics and the National
Institute for Occupational Safety and Health (NIOSH), it is estimated that each
year more than eight million people are affected by carpal tunnel syndrome and
carpal tunnel surgery is the second most common type of surgery with over
230,000 procedures performed annually.
Market Drivers
Introduction of innovative therapies is accelerating the market
growth
Rising demand for effective therapies among patients is boosting
the market growth
Rising spending on public health programs is acting as catalyst
to market growth
Increasing global healthcare expenditure is driving the market
growth for carpal tunnel syndrome drug
Market Restraints
Lack of awareness amongst people about carpal tunnel syndrome is
restraining the market growth
High cost of surgical treatment is hindering the market growth
in the forecast period
Inadequate reimbursement and lack of availability of skilled
professionals are hampering the market growth
Global Carpal Tunnel Syndrome
Drug Market Scope and Market Size:
Global
Carpal tunnel syndrome drug market is segmented on the basis of treatment,
mechanism of action, drugs, route of administration, distribution channel and
end-users. The growth among these specific segments will help users analyze
niche pockets of growth and strategies to approach the market and determine
your core application areas and difference in your target markets.
Based on treatment, the
carpal tunnel syndrome drug market is segmented into medication, integrative
therapy and surgery
Based on mechanism of
action, the carpal tunnel syndrome drug market is segmented as analgesics,
NSAIDs, corticosteroids and others
Based on drugs, the
carpal tunnel syndrome drug market is segmented as ibuprofen, prednisone,
triamcinolone and others
Based on the route of administration,
the carpal tunnel syndrome drug market is segmented into oral and parenteral
Based on the
distribution channel, the carpal tunnel syndrome drug market is segmented as
direct, online pharmacy, retailers and others
Based on end-users, the
carpal tunnel syndrome drug market is segmented into hospitals, homecare,
specialty clinics and others
Global Carpal Tunnel Syndrome
Drug Market Country Level Analysis
The countries covered in
the market report are U.S., Canada and Mexico in North America, Germany,
France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey,
Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe,
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand,
Indonesia, Philippines, Vietnam, Rest of Asia-Pacific in Asia-Pacific, Saudi
Arabia, U.A.E, South Africa, Israel, Egypt, Kuwait, Rest of Middle East and
Africa as a part of Middle East and Africa, Argentina, Brazil, Peru and Rest of
South America as part of South America.
Key Development in the Market
In July 2017, CarpalAID, LLC received approval from the FDA for
CarpalAID patch for the non-invasive treatment of painful carpal tunnel
syndrome symptoms. The approval of CarpalAID patch provides critical medical
relief from painful symptoms of carpal tunnel syndrome.
Competitive Analysis:
Carpal tunnel syndrome
drug market is highly fragmented and the major players have used various
strategies such as new product launches, expansions, agreements, joint
ventures, partnerships, acquisitions, and others to increase their footprints
in this market. The report includes market shares of carpal tunnel syndrome
drug for Global, Europe, North America, Asia-Pacific, South America and Middle
East & Africa.
Major Players:
Major players in the
carpal tunnel syndrome drug market are GlaxoSmithKline plc, ALLERGAN, Pfizer
Inc, Johnson & Johnson Services, Inc, Novartis AG, Teva Pharmaceutical
Industries Ltd, Bristol-Myers Squibb Company, WOCKHARDT, Mylan N.V, Aurobindo
Pharma, Arthrex, Inc, Eisai Co., Ltd, Pressure Profile Systems, Endo
Pharmaceuticals Inc, PAVmed Inc, Avadim Health, Inc, Bioness Inc among others.
Get full details of TOC @ https://www.databridgemarketresearch.com/toc/?dbmr=global-carpal-tunnel-syndrome-drug-market
Reasons
for Buying this Report
This
report provides pin-point analysis for changing competitive dynamics
It
provides a forward looking perspective on different factors driving or
restraining market growth
It
provides a six-year forecast assessed on the basis of how the market is predicted
to grow
It helps
in understanding the key product segments and their future
It
provides pin point analysis of changing competition dynamics and keeps you
ahead of competitors
It helps
in making informed business decisions by having complete insights of market and
by making in-depth analysis of market segments
Access Full Report @ https://www.databridgemarketresearch.com/reports/global-carpal-tunnel-syndrome-drug-market
About
Us:
Data
Bridge Market Research set
forth itself as an unconventional and neoteric Market research and consulting
firm with unparalleled level of resilience and integrated approaches. We are
determined to unearth the best market opportunities and foster efficient
information for your business to thrive in the market
Contact:
Tel:
+1-888-387-2818
Email: Sopan.gedam@databridgemarketresearch.com
Browse
Related Reports @
Pediatric Heart Failure Market
Report This Post
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.
